Definitive Contract W81XWH21C0101
Award Date
9/3/21
Potential Completion Date
1/2/24
Potential Value
$1.1M
Federal Agency
Medical Command
Awardee
Genecapture, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Department of the Army Medical Command to Genecapture, Inc., a for-profit startup company, under the Small Business Innovation Research (SBIR) program. The contract, valued at $249,959.25, is for Phase I feasibility research on Genecapture's CAPTURE technology, which enables rapid identification of genetic signatures of pathogens for infectious disease detection and diagnosis. The award has a total small business set-aside designation. Genecapture...
The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
This is a $1,271,417.59 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a small business contractor. The contract is for a Small Business Technology Transfer (STTR) Phase II research project to develop rapid infectious disease detection solutions using Genecapture's patented CAPTURE technology. The work aims to advance fieldable diagnostic platforms for rapidly identifying and testing antibiotic susceptibility of pathogens,...
The Department of the Air Force Materiel Command Research Laboratory awarded a $284,827 Other Transaction Agreement to Genecapture, Inc., a for-profit small business startup, to research and develop a ruggedized and upgraded version of a commercially available pathogen detector that can be deployed in forward environments. This award is not set aside for any specific business type. Genecapture has received prior Small Business Innovation Research (SBIR) Phase II contracts from the Army,...
This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a for-profit startup company. The $150,523.52 firm-fixed-price contract is for the development of infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications. Genecapture specializes in rapid pathogen detection solutions using their patented CAPTURE technology. This contract supports DTRA's efforts...
The Defense Threat Reduction Agency (DTRA) awarded a $4,541,420.24 Cost Plus Fixed Fee contract to Genecapture, Inc., a for-profit startup company, to develop infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications under the Small Business Technology Transfer (STTR) program. This Phase III STTR contract supports the company's efforts to advance their patented CAPTURE technology, which rapidly identifies genetic signatures of...
The Department of the Army Medical Command awarded a $999,742.97 Small Business Innovation Research (SBIR) Phase II contract to Gama Therapeutics LLC, a for-profit organization, for the development of a "Miniature, Point-of-Care Device for Establishing Sterile Connections in Combat Environments." The contract was awarded on December 8, 2017, with a completion date of October 7, 2020. This fixed-price level of effort contract was awarded under the SBIR program, which provides funding to...
This is a firm fixed-price STTR Phase I contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Giner Inc., a Boston-based research and development firm, for the project "RAPID AND REPROGRAMMABLE ASSAY FOR MULTIPLEXED GENE DETECTION". The contract, with a ceiling value of $166,430.81, was awarded on April 12, 2020 and has a completion date of February 11, 2022. The contract is set aside for small businesses. Giner Inc. is a Subchapter S Corporation that has extensive...
The Department of the Army Medical Command awarded a Small Business Innovation Research (STTR) Phase I purchase order to CFD Research Corporation, a small business, for a project titled "Point-of-Care Nucleic Acid Assays". The firm-fixed-price contract has a potential value of $166,487.59 and a completion date of July 20, 2021. CFD Research is a small business that specializes in engineering services and has previously received prime and subcontract awards from various federal agencies...
This federal contract award, valued at $85,340.00, was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Genedata (USA), Inc., a foreign-owned, self-certified small disadvantaged business. The contract provides for the software license, maintenance, and support of Genedata Screener, the company's proprietary bioinformatics software platform, to support critical research initiatives,...